HomeCompareAMRZF vs JNJ

AMRZF vs JNJ: Dividend Comparison 2026

AMRZF yields 446.73% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AMRZF wins by $25984.23M in total portfolio value
10 years
AMRZF
AMRZF
● Live price
446.73%
Share price
$0.45
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25984.26M
Annual income
$18,040,278,691.88
Full AMRZF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — AMRZF vs JNJ

📍 AMRZF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAMRZFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AMRZF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AMRZF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AMRZF
Annual income on $10K today (after 15% tax)
$37,971.86/yr
After 10yr DRIP, annual income (after tax)
$15,334,236,888.10/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, AMRZF beats the other by $15,334,232,902.11/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AMRZF + JNJ for your $10,000?

AMRZF: 50%JNJ: 50%
100% JNJ50/50100% AMRZF
Portfolio after 10yr
$12992.14M
Annual income
$9,020,141,690.64/yr
Blended yield
69.43%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

AMRZF
No analyst data
Altman Z
244726.6
Piotroski
2/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AMRZF buys
0
JNJ buys
8
PoliticianChamberTickerTypeAmountDate
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Lloyd Doggett🏢 House$JNJ▲ Buy$1,001 - $15,0002025-12-09
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002025-11-20
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$JNJ▲ Buy$1,001 - $15,0002025-11-05
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Jared Moskowitz🏢 House$JNJ▼ Sell$1,001 - $15,0002025-10-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAMRZFJNJ
Forward yield446.73%2.13%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$25984.26M$30.3K
Annual income after 10y$18,040,278,691.88$4,689.40
Total dividends collected$25274.36M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: AMRZF vs JNJ ($10,000, DRIP)

YearAMRZF PortfolioAMRZF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$55,373$44,672.77$10,592$272.30+$44.8KAMRZF
2$290,432$231,182.73$11,289$357.73+$279.1KAMRZF
3$1,443,995$1,133,232.99$12,123$472.89+$1.43MAMRZF
4$6,810,788$5,265,713.13$13,141$629.86+$6.80MAMRZF
5$30,499,145$23,211,602.51$14,408$846.81+$30.48MAMRZF
6$129,777,123$97,143,037.82$16,021$1,151.60+$129.76MAMRZF
7$525,173,681$386,312,159.34$18,122$1,588.22+$525.16MAMRZF
8$2,022,966,772$1,461,030,933.15$20,930$2,228.20+$2022.95MAMRZF
9$7,424,279,961$5,259,705,514.97$24,792$3,191.91+$7424.26MAMRZF
10$25,984,258,250$18,040,278,691.88$30,274$4,689.40+$25984.23MAMRZF

AMRZF vs JNJ: Complete Analysis 2026

AMRZFStock

Arena Minerals Inc., a copper and lithium exploration company, engages in the acquisition, exploration, and development of mineral properties in South America. It holds 100% interest in the Antofalla lithium brine projects, which cover an area of 4,000 hectares located in Salar de Antofalla, Argentina; and 100% interest in the Sal de la Puna lithium project that covers approximately 11,000 hectares located in the Puna region of Salta province, Argentina. It also holds interest in the Atacama copper project, which includes the Pampa Union property that covers an area of approximately 5,000 hectares located in the Antofagasta region of Chile. The company was formerly known as Antofagasta Gold Inc. and changed its name to Arena Minerals Inc. in December 2013. Arena Minerals Inc. was incorporated in 1995 and is headquartered in Toronto, Canada.

Full AMRZF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this AMRZF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AMRZF vs SCHDAMRZF vs JEPIAMRZF vs OAMRZF vs KOAMRZF vs MAINAMRZF vs ABBVAMRZF vs MRKAMRZF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.